Therefore, directly exploring the differences in brain function and structure between APOE ɛ2 and APOE ɛ4 carriers may help us understand the reasons for the protective and impaired cognitive function associated with these two genotypes, the pathogenesis of AD, and discover novel cognitive-related imaging markers. Here, APOE is linked to Alzheimer disease.